Incorporating robotic-assisted surgery for endometrial cancer staging: Analysis of morbidity and costs

Giorgio Bogani, Francesco Multinu, Sean Christopher Dowdy, William Arthur Cliby, Timothy O. Wilson, Bobbie S. Gostout, Amy L. Weaver, Bijan J Borah, Jill M. Killian, Akash Bijlani, Stefano Angioni, Andrea Mariani

Research output: Contribution to journalArticle

43 Scopus citations

Abstract

Objective: To evaluate how the introduction of robotic-assisted surgery affects treatment-related morbidity and cost of endometrial cancer (EC) staging. Methods: We retrospectively reviewed the records of consecutive patients with stage I-III EC undergoing surgical staging between 2007 and 2012 at our institution. Costs (from surgery to 30. days after surgery) were set based on the Medicare cost-to-charge ratio for each year and inflated to 2014 values. Inverse probability weighting (IPW) was used to decrease the allocation bias when comparing outcomes between surgical groups. Results: We focused our analysis on the 251 EC patients who had robotic-assisted surgery and the 384 who had open staging. During the study period, the use of robotic-assisted surgery increased and open staging decreased (P

Original languageEnglish (US)
JournalGynecologic Oncology
DOIs
StateAccepted/In press - Nov 24 2015

    Fingerprint

Keywords

  • Costs
  • Endometrial cancer
  • Lymphadenectomy
  • Robotic surgery

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Bogani, G., Multinu, F., Dowdy, S. C., Cliby, W. A., Wilson, T. O., Gostout, B. S., Weaver, A. L., Borah, B. J., Killian, J. M., Bijlani, A., Angioni, S., & Mariani, A. (Accepted/In press). Incorporating robotic-assisted surgery for endometrial cancer staging: Analysis of morbidity and costs. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2016.02.016